Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Redwood City, CA
SEC filing record 1 source field available
Fiscal year end
31 December
Jasper Therapeutics, Inc. has filed 469 SEC EDGAR filings since 13 Sep 2019

SEC filing history

Showing 151-175 of 469 matching filings.

Per page
25
Current page
7
4

4 filing

Filing date
20 Feb 2024
Reporting date
15 Feb 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
20 Feb 2024
Reporting date
15 Feb 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-91228

SC 13G/A

Filing date
14 Feb 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-91228

SC 13G/A

Filing date
14 Feb 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-91228

AMENDMENT NO. 1 TO SCHEDULE 13G

Filing date
14 Feb 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
12 Feb 2024
Reporting date
08 Feb 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D/A File 005-91228

SC 13D/A

Filing date
12 Feb 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

OWNERSHIP DOCUMENT

Filing date
09 Feb 2024
Reporting date
08 Feb 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D/A File 005-91228

AMENDMENT NO. 1 TO THE SCHEDULE 13D

Filing date
09 Feb 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
424B5 File 333-271500

PROSPECTUS SUPPLEMENT

Filing date
07 Feb 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-39138

CURRENT REPORT

Filing date
06 Feb 2024
Reporting date
06 Feb 2024
Next action
Verify source filing
SC 13G/A File 005-91228

SC 13G/A

Filing date
05 Feb 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-91228

AMENDMENT NO. 1 TO SCHEDULE 13G

Filing date
02 Feb 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-39138

CURRENT REPORT

Filing date
04 Jan 2024
Reporting date
03 Jan 2024
Next action
Verify source filing
8-K File 001-39138

CURRENT REPORT

Filing date
02 Jan 2024
Reporting date
02 Jan 2024
Next action
Verify source filing
8-K File 001-39138

CURRENT REPORT

Filing date
20 Dec 2023
Reporting date
15 Dec 2023
Next action
Verify source filing
4

4 filing

Filing date
30 Nov 2023
Reporting date
28 Nov 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
22 Nov 2023
Reporting date
21 Nov 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
20 Nov 2023
Reporting date
16 Nov 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
DEF 14A File 001-39138

PROXY STATEMENT

Filing date
20 Nov 2023
Reporting date
15 Dec 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
PRE 14A File 001-39138

PROXY STATEMENT

Filing date
09 Nov 2023
Reporting date
09 Nov 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
10-Q File 001-39138

QUARTERLY REPORT

Filing date
09 Nov 2023
Reporting date
30 Sep 2023
Next action
Verify source filing
8-K File 001-39138

CURRENT REPORT

Filing date
09 Nov 2023
Reporting date
09 Nov 2023
Next action
Verify source filing
4

4 filing

Filing date
02 Nov 2023
Reporting date
01 Nov 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
3

3 filing

Filing date
02 Nov 2023
Reporting date
01 Nov 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .